Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment Failure

NCT03502200 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT03502200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03502200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Switching to a Vaping Device: Evaluating Risk Reduction Among Quitline Treatment Failure
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Not applicable
Overall status
Completed
Start date
October 15, 2020
Completion date
January 31, 2023
Enrollment
350 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking, cigarette